Kemwell’s biopharmaceutical facilities are located in Bangalore, India and were built with technical guidance from BoehringerIngelheim, providing customers with state-of-the-art technology along with the benefit of cost-effective manufacturing. The 15,000 sq. m. facility consist of a cGMP drug substance manufacturing facility with 2x2000L bioreactors and a sterile fill and finish facility for cGMP drug product manufacturing with a floor for process development laboratories to support production of protein therapeutics from mammalian-cell culture or microbial fermentation.
- Method development
- Method validation
- Reference standard charaterization
- Stability studies